CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice
about
Role of mitochondria in nonalcoholic fatty liver diseaseCD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infectionHypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsStructure-function of CD36 and importance of fatty acid signal transduction in fat metabolismHepatic Steatosis as a Marker of Metabolic Dysfunction.Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.The Mechanisms Underlying the Hypolipidaemic Effects of Grifola frondosa in the Liver of Rats.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchHepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice.Pathogenesis and Prevention of Hepatic Steatosis.Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression.Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.Cd36 knockout mice are protected against lithogenic diet-induced gallstones.Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.Scopoletin Supplementation Ameliorates Steatosis and Inflammation in Diabetic Mice.Cluster-determinant 36 (CD36) impacts on vitamin E postprandial response.
P2860
Q27028142-D112DF68-EC5B-45CD-8A45-3E316837761CQ27468740-16828735-AB85-4F6A-AB04-9AECE02A9C3AQ33884666-36C36B58-6D06-4A97-888D-6FA2C8B88391Q34800989-A9031B10-A19D-4C17-8781-DA1DC7A68BB6Q35087570-6FD28188-9CBB-4FED-8930-6A2E4A101742Q35809069-F850ABA9-F274-4138-9955-4C3962F0C055Q35998233-3A9CFDE0-9296-455D-95FD-605812EAEB70Q36106490-F790AEC0-5105-4D76-B18A-F94414CCE35CQ36129673-0B8E99F5-BC4D-4808-AE23-3E8AA51E7474Q36521129-F265D1BA-9C35-4475-B698-1263AB65B46BQ36567359-9268F67C-BFF0-4A69-9A28-FB6BD588EBE0Q36812508-A08DCDEB-0B41-448F-ADD6-F0CC88EC5F94Q38760996-86DA418F-87D2-4F28-961A-505AB3F5FC5FQ41461350-4C68F94D-6D66-4C2C-A36A-9224F8FC21A7Q46001740-6CD7E4E8-4E1E-4AFC-895D-85F832E681DFQ47152443-4D87F08F-4CB1-46DF-BE29-AD398D6F789CQ47786314-B83F86E5-596F-4A73-BE8B-0995E0C2A4B7Q48573325-30B622DD-1BDF-45E3-8CA1-32FE7CA55D45
P2860
CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD36 deletion reduces VLDL sec ...... epatic steatosis in ob/ob mice
@en
CD36 deletion reduces VLDL sec ...... patic steatosis in ob/ob mice.
@nl
type
label
CD36 deletion reduces VLDL sec ...... epatic steatosis in ob/ob mice
@en
CD36 deletion reduces VLDL sec ...... patic steatosis in ob/ob mice.
@nl
prefLabel
CD36 deletion reduces VLDL sec ...... epatic steatosis in ob/ob mice
@en
CD36 deletion reduces VLDL sec ...... patic steatosis in ob/ob mice.
@nl
P2093
P2860
P356
P1476
CD36 deletion reduces VLDL sec ...... epatic steatosis in ob/ob mice
@en
P2093
Elizabeth M Brunt
Fatiha Nassir
Nada A Abumrad
Okunade L Adewole
P2860
P304
P356
10.1194/JLR.M037812
P577
2013-08-20T00:00:00Z